Amedeo Smart

Free Medical Literature Service

 

Amedeo

Obesity
  Free Subscription

Articles published in
Eur J Endocrinol
    March 2024
  1. VAN BEIJSTERVELDT IALP, van Zelst BD, Dorrepaal DJ, van den Berg SAA, et al
    Early life poly- and perfluoroalkyl substances (PFAS) levels and adiposity in the first 2 years of life.
    Eur J Endocrinol. 2024 Mar 30:lvae039. doi: 10.1093.
    >> Share

  2. GATTA-CHERIFI B, Mohammedi K, Cariou T, Poitou C, et al
    Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trial.
    Eur J Endocrinol. 2024 Mar 7:lvae024. doi: 10.1093.
    >> Share

    February 2024
  3. FERNANDEZ-GARCIA P, Taxeras SD, Reyes-Farias M, Gonzalez L, et al
    Claudin-1 as a novel target gene induced in obesity and associated to inflammation, fibrosis and cell differentiation.
    Eur J Endocrinol. 2024 Feb 20:lvae018. doi: 10.1093.
    >> Share

    November 2023
  4. LEE J, Jung JH, Kim J, Jeong C, et al
    Associations between body composition and the risk of fracture according to bone mineral density in postmenopausal women: a population-based database cohort study.
    Eur J Endocrinol. 2023;189:527-536.
    >> Share

    October 2023
  5. GATTA-CHERIFI B, Laboye A, Gronnier C, Monsaingeon-Henry M, et al
    A novel pathogenic variant in MRAP2 in an obese patient with successful outcome of bariatric surgery.
    Eur J Endocrinol. 2023;189:K15-K18.
    >> Share

  6. PLUIMAKERS VG, van Atteveld JE, de Winter DTC, Bolier M, et al
    Prevalence, risk factors and optimal way to determine overweight, obesity and morbid obesity, in the first Dutch cohort of 2,338 long-term survivors of childhood cancer: a DCCSS-LATER study.
    Eur J Endocrinol. 2023 Oct 14:lvad139. doi: 10.1093.
    >> Share

    August 2023
  7. JONES TH, Dobs AS, Randeva H, Moore W, et al
    Leflutrozole in Male Obesity-Associated Hypogonadotropic Hypogonadism: Ph 2b Double-Blind Randomised Controlled Trial.
    Eur J Endocrinol. 2023 Aug 14:lvad099. doi: 10.1093.
    >> Share

  8. INDER WJ, Grossmann M
    Obesity and 'functional hypogonadism' - mechanisms and management: Commentary on EJE-22-1110 "Leflutrozole in Male Obesity-Associated Hypogonadotropic Hypogonadism: Ph 2b Double-Blind RCT".
    Eur J Endocrinol. 2023 Aug 7:lvad100. doi: 10.1093.
    >> Share

    July 2023
  9. TRUEBA-TIMMERMANS DJ, Grootjen LN, Juriaans AF, Mahabier EF, et al
    Cognitive function during 3 years of growth hormone in previously growth hormone-treated young adults with Prader-Willi syndrome.
    Eur J Endocrinol. 2023;189:132-139.
    >> Share

  10. OLLILA MM, Hoek A, Piltonen TT
    The association between polycystic ovary syndrome and early cardiovascular disease morbidity strengthens.
    Eur J Endocrinol. 2023;189:R4-R5.
    >> Share

  11. SIMCHONI M, Derazne E, Pinhas-Hamiel O, Cukierman-Yaffe T, et al
    Adolescent body mass index and cognitive performance: a nationwide study of 2.48 million Israeli adolescents.
    Eur J Endocrinol. 2023;188:630-640.
    >> Share

    June 2023
  12. EZQUERRO S, Tuero C, Becerril S, Valenti V, et al
    Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated NAFLD.
    Eur J Endocrinol. 2023 Jun 26:lvad071. doi: 10.1093.
    >> Share

  13. DWIVEDI AK, Vishwakarma D, Dubey P, Reddy S, et al
    Association of polycystic ovary syndrome with cardiovascular disease among female hospitalizations in the United States.
    Eur J Endocrinol. 2023;188:555-563.
    >> Share

    April 2023
  14. CANNARELLA R, Caruso M, Condorelli RA, Timpanaro TA, et al
    Testicular volume in 268 children and adolescents followed-up for childhood obesity-a retrospective cross-sectional study.
    Eur J Endocrinol. 2023;188:331-342.
    >> Share

    March 2023
  15. SONNEFELD L, Rohmann N, Geisler C, Laudes M, et al
    Is human obesity an inflammatory disease of the hypothalamus?
    Eur J Endocrinol. 2023 Mar 8:lvad030. doi: 10.1093.
    >> Share

  16. BECKHAUS J, Friedrich C, Boekhoff S, Calaminus G, et al
    Outcome after pediatric craniopharyngioma: the role of age at diagnosis and hypothalamic damage.
    Eur J Endocrinol. 2023;188:lvad027.
    >> Share

    February 2023
  17. GU P, Ding K, Lu L, Zhang Y, et al
    Compromised browning in white adipose tissue of ageing people.
    Eur J Endocrinol. 2023;188:lvad014.
    >> Share

    October 2022
  18. PEKKARINEN L, Kantonen T, Rebelos E, Latva-Rasku A, et al
    Obesity risk is associated with brain glucose uptake and insulin resistance.
    Eur J Endocrinol. 2022 Oct 1. pii: EJE-22-0509. doi: 10.1530/EJE-22-0509.
    >> Share

    September 2022
  19. VILACA T, Evans A, Gossiel F, Paggiosi M, et al
    Fat, adipokines, bone structure and bone regulatory factors associations in obesity.
    Eur J Endocrinol. 2022 Sep 1. pii: EJE-22-0530. doi: 10.1530/EJE-22-0530.
    >> Share

    June 2022
  20. ROSEN CJ
    3E: My Quarter Century Quest to Understand the Paradox of Marrow Adiposity.
    Eur J Endocrinol. 2022 Jun 1. pii: EJE-22-0499. doi: 10.1530/EJE-22-0499.
    >> Share

    May 2022
  21. BLAGOJEVIC C, Heung T, Malecki S, Ying S, et al
    Hypertriglyceridemia in young adults with a 22q11.2 microdeletion.
    Eur J Endocrinol. 2022;187:91-99.
    >> Share

    April 2022
  22. MATHIESEN DS, Lund A, Holst JJ, Knop FK, et al
    THERAPY OF ENDOCRINE DISEASE: Amylin and calcitonin - physiology and pharmacology.
    Eur J Endocrinol. 2022;186:R93-R111.
    >> Share

  23. GOEDEGEBUURE WJ, van der Steen M, Smeets CCJ, Kerkhof GF, et al
    SGA-born adults with postnatal catch-up have a persistently unfavorable metabolic health profile and increased adiposity at age 32 years.
    Eur J Endocrinol. 2022 Apr 1. pii: EJE-21-1130. doi: 10.1530/EJE-21-1130.
    >> Share

    March 2022
  24. HUYNH K, Klose M, Krogsgaard K, Drejer J, et al
    Randomized Controlled Trial of Tesomet for Weight Loss in Hypothalamic Obesity.
    Eur J Endocrinol. 2022 Mar 1. pii: EJE-21-0972. doi: 10.1530/EJE-21-0972.
    >> Share

  25. RUIZ S, Vazquez F, Pellitero S, Puig Domingo M, et al
    Pituitary dysfunction in obesity.
    Eur J Endocrinol. 2022 Mar 1. pii: EJE-21-0899. doi: 10.1530/EJE-21-0899.
    >> Share

  26. DICHTEL LE, Haines MS, Gerweck AV, Bollinger B, et al
    Impact of GH administration on skeletal endpoints in adults with overweight/obesity.
    Eur J Endocrinol. 2022 Mar 1. pii: EJE-21-1061. doi: 10.1530/EJE-21-1061.
    >> Share

    February 2022
  27. KOH HE, van Vliet S, Cao C, Patterson BW, et al
    Effect of obstructive sleep apnea on glucose metabolism.
    Eur J Endocrinol. 2022;186:457-467.
    >> Share

  28. LAUGESEN K, Sorensen HT, Jorgensen JOL, Petersen I, et al
    Prenatal exposure to glucocorticoids and the prevalence of overweight or obesity in childhood.
    Eur J Endocrinol. 2022 Feb 1. pii: EJE-21-0846.R1. doi: 10.1530/EJE-21-0846.
    >> Share

  29. DHINDSA S, Ghanim H, Jenkins T, Inge TH, et al
    High prevalence of subnormal testosterone in obese adolescent males: reversal with bariatric surgery.
    Eur J Endocrinol. 2022;186:319-327.
    >> Share

  30. KUFE C, Micklesfield LK, Masemola M, Chikowore T, et al
    Increased Risk for Type 2 Diabetes in Relation to Adiposity in Middle-Aged Black South African Men compared to Women.
    Eur J Endocrinol. 2022 Feb 1. pii: EJE-21-0527. doi: 10.1530/EJE-21-0527.
    >> Share

    January 2022
  31. LOH NY, Humphreys E, Karpe F, Tomlinson JW, et al
    Sex hormones, adiposity, and metabolic traits in men and women: a Mendelian Randomisation study.
    Eur J Endocrinol. 2022 Jan 1. pii: EJE-21-0703.R2. doi: 10.1530/EJE-21-0703.
    >> Share

    December 2021
  32. SONG Z, Gao M, Lv J, Yu C, et al
    Metabolically healthy obesity, transition to unhealthy phenotypes and type 2 diabetes in 0.5 million Chinese adults: The China Kadoorie Biobank.
    Eur J Endocrinol. 2021 Dec 1. pii: EJE-21-0743.R1. doi: 10.1530/EJE-21-0743.
    >> Share

  33. MAN S, Gao Y, Lv J, Tong M, et al
    Metabolically healthy obesity was significantly associated with increased risk of gallstones.
    Eur J Endocrinol. 2021 Dec 1. pii: EJE-21-0802.R2. doi: 10.1530/EJE-21-0802.
    >> Share

  34. MOHSENI-TAKALLOO S, Beigrezaei S, Yazdanpanah Z, Rajaie SH, et al
    Does exercise beneficially affect sex hormones when added to hypo-caloric diets in adults with overweight or obesity? A systematic review and meta-analysis of controlled clinical trials.
    Eur J Endocrinol. 2021 Dec 1. pii: EJE-21-0675.R1. doi: 10.1530/EJE-21-0675.
    >> Share

    November 2021
  35. DIETZ DE LOOS A, Jiskoot G, Beerthuizen A, Busschbach J, et al
    Metabolic health during a randomized controlled lifestyle intervention in women with PCOS.
    Eur J Endocrinol. 2021;186:53-64.
    >> Share

  36. RUSSELL N, Hoermann R, Cheung AS, Zajac JD, et al
    Effects of estradiol on fat in men undergoing androgen deprivation therapy: a randomized trial.
    Eur J Endocrinol. 2021;186:9-23.
    >> Share

  37. ZHANG J, Chen X, Liu W, Zhang C, et al
    Metabolic surgery improves the unbalanced proportion of peripheral blood myeloid dendritic cells and T lymphocytes in obese patients.
    Eur J Endocrinol. 2021;185:819-829.
    >> Share

  38. MANGOLIM AS, Brito LAR, Nunes-Nogueira VDS
    Effectiveness of testosterone replacement in men with obesity: a systematic review and meta-analysis.
    Eur J Endocrinol. 2021 Nov 1. pii: EJE-21-0473.R1. doi: 10.1530/EJE-21-0473.
    >> Share

  39. YANG R, Hu Y, Lee CH, Liu Y, et al
    PM20D1 Is a Circulating Biomarker Closely Associated with Obesity, Insulin resistance and Metabolic Syndrome.
    Eur J Endocrinol. 2021 Nov 1. pii: EJE-21-0847.R1. doi: 10.1530/EJE-21-0847.
    >> Share

    October 2021
  40. ROMERO-RUIZ A, Pineda B, Ovelleiro D, Perdices-Lopez C, et al
    Molecular diagnosis of polycystic ovary syndrome in obese and non-obese women by targeted plasma miRNA profiling.
    Eur J Endocrinol. 2021;185:637-652.
    >> Share

    September 2021
  41. ANDERSEN MR, Suppli MP, Bagger JI, Christensen MB, et al
    MECHANISMS IN ENDOCRINOLOGY: The physiology of neuronostatin.
    Eur J Endocrinol. 2021;185:R93-R101.
    >> Share

    August 2021
  42. NOGUEIRAS R
    MECHANISMS IN ENDOCRINOLOGY: The gut-brain axis: regulating energy balance independent of food intake.
    Eur J Endocrinol. 2021;185:R75-R91.
    >> Share

    June 2021
  43. LEITER A, Carroll E, De Alwis S, Brooks D, et al
    Metabolic disease and adverse events from immune checkpoint inhibitors.
    Eur J Endocrinol. 2021;184:857-865.
    >> Share

    May 2021
  44. GROOTJEN LN, Rutges JPHJ, Damen L, Donze SH, et al
    Effects of 8 years of growth hormone treatment on scoliosis in children with Prader-Willi syndrome.
    Eur J Endocrinol. 2021;185:47-55.
    >> Share

  45. DAMEN L, Grootjen LN, Donze SH, de Graaff LCG, et al
    Bone mineral density during 3 years of growth hormone in previously GH-treated young adults with PWS.
    Eur J Endocrinol. 2021;184:773-782.
    >> Share

  46. MCNEILL BT, Suchacki KJ, Stimson RH
    MECHANISMS IN ENDOCRINOLOGY: Human brown adipose tissue as a therapeutic target: warming up or cooling down?
    Eur J Endocrinol. 2021;184:R243-R259.
    >> Share

  47. SUBRAMANIAN A, Anand A, Adderley NJ, Okoth K, et al
    Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study.
    Eur J Endocrinol. 2021;184:637-645.
    >> Share

  48. DE ZEGHER F, Ibanez L
    On the rising incidence of early breast development: puberty as an adaptive escape from ectopic adiposity in mismatch girls.
    Eur J Endocrinol. 2021 May 1. pii: EJE-21-0287. doi: 10.1530/EJE-21-0287.
    >> Share

  49. LEGER J, Delcour C, De Roux N, Carel JC, et al
    Response to letter to the editor (from De Zegher and Ibanes) (On the rising incidence of early breast development: puberty as an adaptive escape from ectopic adiposity in mismatch girls).
    Eur J Endocrinol. 2021 May 1. pii: EJE-21-0445. doi: 10.1530/EJE-21-0445.
    >> Share

    April 2021
  50. REYES M, Gonzalez L, Ibeas K, Cereijo R, et al
    White adipose tissue-infiltrated CD11b+ myeloid cells are a source of S100A4, a new potential marker of hepatic damage.
    Eur J Endocrinol. 2021;184:533-541.
    >> Share

  51. JUN JE, Kang M, Jin SM, Kim K, et al
    Additive effect of low skeletal muscle mass and abdominal obesity on coronary artery calcification.
    Eur J Endocrinol. 2021 Apr 1. pii: EJE-20-0885.R1. doi: 10.1530/EJE-20-0885.
    >> Share

  52. STENSEN S, Gasbjerg LS, Krogh LL, Skov-Jeppesen K, et al
    Effects of endogenous GIP in patients with type 2 diabetes.
    Eur J Endocrinol. 2021 Apr 1. pii: EJE-21-0135.R1. doi: 10.1530/EJE-21-0135.
    >> Share

    January 2021
  53. VALDES N, Tirosh A, Keil M, Stratakis CA, et al
    Pediatric Cushing's syndrome: greater risk of being overweight or obese after long-term remission and its predictive factors.
    Eur J Endocrinol. 2021;184:179-187.
    >> Share

    December 2020
  54. LAPAUW B, Kaufman JM
    MANAGEMENT OF ENDOCRINE DISEASE: Rationale and current evidence for testosterone therapy in the management of obesity and its complications.
    Eur J Endocrinol. 2020;183:R167-R183.
    >> Share

    November 2020
  55. BEAVERS KM, Greene KA, Yu EW
    MANAGEMENT OF ENDOCRINE DISEASE: Bone complications of bariatric surgery: updates on sleeve gastrectomy, fractures, and interventions.
    Eur J Endocrinol. 2020;183:R119-R132.
    >> Share

  56. POITOU C, Mosbah H, Clement K
    MECHANISMS IN ENDOCRINOLOGY: Update on treatments for patients with genetic obesity.
    Eur J Endocrinol. 2020;183:R149-R166.
    >> Share

    September 2020
  57. VAN DER VALK ES, van der Voorn B, Iyer AM, van den Berg S, et al
    In adults with obesity, copeptin is linked with BMI but is not associated with long-term exposure to cortisol and cortisone.
    Eur J Endocrinol. 2020 Sep 1. pii: EJE-20-0077.R1. doi: 10.1530/EJE-20-0077.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016